Traders are waiting for Iran’s response to a nuclear deal proposal that could raise the country’s exports
SA is not getting the basics of reliable trade infrastructure right and this means the country’s fiscus will be more fragile in future.
Numsa is waiting for the strike certificate to be issued and in the meantime is mobilising members for a total shut down of all smelters at Samancor
Voting for the top five positions of the provincial leadership continued late into Sunday evening
The continuous selling of units is helping the company to reduce its high debt levels
An employee at the Kruger National Park opened a case at the Skukuza police station in Mpumalanga
Former CEO Mike Metz stepped down from the helm on his 65th birthday, but will stay on in an advisory capacity
By converting farmland into sustainably managed rangeland to create a wildlife conservancy where cattle and wild animals can coexist, eco-tourism provides jobs for local people
Chelsea coach plays down clashes with Spurs counterpart saying heat was on everywhere
Porsche Taycan Turbo S laps the famous German circuit in seven minutes and 33 seconds
London — The European drugs regulator is bolstering its response to escalating cases of monkeypox, days after the World Health Organization declared the outbreak a global health emergency.
The European Medicines Agency’s emergency task force — an advisory body tasked with handling regulatory activities during a public-health emergency — will now tackle both Covid-19 and monkeypox, the regulator said on Wednesday.
The task force will offer scientific advice, review the available scientific data, and co-ordinate independent monitoring studies on interventions, such as the Bavarian Nordic vaccine and Siga Technologies antiviral, which are being used to combat monkeypox.
Monkeypox is a virus that typically causes mild symptoms including fever, aches and pus-filled skin lesions. People tend to recover on their own within two to four weeks, according to the WHO.
First identified in monkeys, the virus is transmitted chiefly through close contact, and is typically endemic to Africa.
After initial reports of European cases in May, cases have since ballooned to more than 16,000 from more than 75 countries. Five deaths, all of which occurred in Africa, have been reported so far.
On Tuesday, British health agencies secured funding to develop a standardised approach to test the performance of vaccines being used or in development against monkeypox.
It is difficult to predict how the outbreak will unfold, said Carlos Maluquer de Motes, who runs a research group studying poxvirus biology at the University of Surrey.
“There has been no decline in the number of confirmed monkeypox cases since the beginning of the outbreak. This indicates that the public health measures deployed so far have had minimal impact and that the outbreak is unlikely to die off by natural causes.”
Would you like to comment on this article? Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.